Similar articles

• [Hepatitis B: serological strategy and epidemiological aspects].

  Penna R, Rabagliati AM. Penna R, et al. G Batteriol Virol Immunol. 1981 Jan-Jun;74(1-6):145-62. G Batteriol Virol Immunol. 1981. PMID: 7030851 Review. Italian. No abstract available.
• Hepatitis B markers among dialysis patients without hepatitis B surface antigen or antibody.

  Kelly TJ, Sanchez TV, Patterson MJ, Mayor GH. Kelly TJ, et al. Proc Clin Dial Transplant Forum. 1980;10:165-8. Proc Clin Dial Transplant Forum. 1980. PMID: 7346842 No abstract available.
• [Viral markers of hepatitis A and B: main characteristics and clinical significance].

  Lyra LG. Lyra LG. Arq Gastroenterol. 1983 Jul-Sep;20(3):117-22. Arq Gastroenterol. 1983. PMID: 6329145 Portuguese.
• [Comparative study of the "e" system (HBeAG/anti-HBeAg) and core antibodies in aggressive chronic hepatitis and liver cirrhosis].

  Marinucci G, Muglia M, Di Giacomo C, Petrucci L, Mancini R, Costa F, Bachetoni A. Marinucci G, et al. Quad Sclavo Diagn. 1981 Mar;17(1):81-5. Quad Sclavo Diagn. 1981. PMID: 7313073 Italian. No abstract available.
• [Elements with prognostic value in the chronic evolution of viral hepatitis. Markers of the evolution].

  Banciu T. Banciu T. Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna. 1986 Mar-Apr;38(2):161-70. Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna. 1986. PMID: 2875504 Review. Romanian. No abstract available.